A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT01562275 · COMPLETED
Trial details
- NCT number
- NCT01562275
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2015-01-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.